KERRY GILLILAND: Open Payments
NPI 1063078186 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,478 in 109 payments from 31 companies in 2025. Trend: 2023 $1,581 · 2024 $2,384 · 2025 $2,478
Food & beverage: $2,478
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $304 |
| UCB, Inc. | 8 | $250 |
| Biogen, Inc. | 10 | $241 |
| Celgene Corporation | 6 | $158 |
| Novartis Pharmaceuticals Corporation | 6 | $152 |
| PFIZER INC. | 5 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $110 |
| TG Therapeutics, Inc. | 3 | $103 |
| Lundbeck LLC | 4 | $97 |
| ARGENX US, INC. | 3 | $90 |
Products named: QULIPTA, TYSABRI, ZEPOSIA, KESIMPTA, Rystiggo, HYQVIA, BRIUMVI, Zilbrysq.
Industry payments across GA — which companies pay providers there.
